Workflow
MediWound(MDWD)
icon
Search documents
MediWound(MDWD) - 2022 Q1 - Earnings Call Transcript
2022-05-17 16:04
MediWound Ltd. (NASDAQ:MDWD) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Monique Kosse - IR Sharon Malka - CEO Boaz Gur-Lavie - Chief Financial Officer Ofer Gonen - Board Member Lior Rosenberg - Chief Medical Officer Cyaandi R. Dove - Investigator, Advanced Wound & Ankle Center, Las Vegas Conference Call Participants Unidentified Analyst - Cowen and Company Kevin DeGeeter - Oppenheimer Arthur He - H.C. Wainwright Operator Good day and welcome to the MediWound First Quarter ...
MediWound(MDWD) - 2021 Q4 - Earnings Call Transcript
2022-03-17 16:31
MediWound Ltd. (NASDAQ:MDWD) Q4 2021 Earnings Conference Call March 17, 2022 8:30 AM ET Company Participants Monique Kosse - Investor Relations Sharon Malka - Chief Executive Officer Boaz Gur-Lavie - Chief Financial Officer Conference Call Participants Josh Jennings - Cowen Kevin DeGeeter - Oppenheimer Ryan Zimmerman - BTIG Swayampakula Ramakanth - H.C. Wainwright Nathan Weinstein - Aegis Capital Operator Good day and thank you for standing by. Welcome to MediWound Fourth Quarter and Year End 2021 Conferenc ...
MediWound(MDWD) - 2021 Q4 - Annual Report
2022-03-17 11:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________________ to ____________________ OR ☐SHELL COMPANY REPORT PURS ...
MediWound(MDWD) - 2022 Q1 - Quarterly Report
2022-03-17 11:05
Exhibit 99.1 MediWound Reports Fourth Quarter and Full Year 2021 Financial Results Full-Year 2021 Total Revenues of $23.8 Million; Product Revenues Up 46% Positive Top-Line Data for EscharEx Phase 2 Clinical Trial, with Full Data Set Anticipated in Second Quarter 2022 Raised Gross Proceeds of $10 Million through Public Equity Of ering Conference Call Begins Today at 8:30 am ET YAVNE, Israel, March 17, 2022 -- MediWound Ltd. (Nasdaq: MDWD) (the "Company"), a fully-integrated biopharmaceutical company focused ...
MediWound(MDWD) - 2021 Q3 - Earnings Call Transcript
2021-11-16 16:50
MediWound Ltd. (NASDAQ:MDWD) Q3 2021 Results Conference Call November 16, 2021 8:30 AM ET Company Participants Monique Kosse - LifeSci Advisors Sharon Malka - CEO Boaz Gur-Lavie - CFO Conference Call Participants Bryan Bergin - Cowen and Company Ryan Zimmerman - BTIG Kevin DeGeeter - Oppenheimer Swayampakula Ramakanth - H.C. Wainwright Operator Good day, and welcome to the MediWound Third Quarter 2021 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the call ...
MediWound(MDWD) - 2021 Q2 - Earnings Call Transcript
2021-08-10 21:09
Mediwound Ltd (NASDAQ:MDWD) Q2 2021 Earnings Conference Call August 10, 2021 8:30 AM ET Company Participants Jeremy Feffer - LifeSci Advisors Sharon Malka - CEO Boaz Gur-Lavie - CFO Conference Call Participants Kevin DeGeeter - Oppenheimer Joshua Jennings - Cowen and Company Swayampakula Ramakanth - H.C. Wainwright & Co. Operator Good day, and thank you for standing by. Welcome to the Q2 MediWound 2021 Conference Call. [Operator Instructions]. I would now like to hand the conference over to your speaker tod ...
Mediwound (MDWD) Investor Presentation - Slideshow
2021-05-17 18:38
May 2021 I Nasdaq: MDWD Company Presentation | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
MediWound(MDWD) - 2021 Q1 - Earnings Call Transcript
2021-05-08 19:14
MediWound Ltd (NASDAQ:MDWD) Q1 2021 Earnings Conference Call May 5, 2021 8:30 AM ET Company Participants Jeremy Feffer - Managing Director Sharon Malka - Chief Executive Officer Boaz Gur-Lavie - Chief Financial Officer Conference Call Participants Susan Chor - Oppenheimer Nathan Weinstein - Aegis Bryan Bergin - Cowen Operator Good day, and thank you for standing by, and welcome to the Quarter 1 MediWound 2021 Conference Call. [Operator Instructions] Please be advised that today's conference is recorded. [Op ...
MediWound(MDWD) - 2020 Q4 - Earnings Call Transcript
2021-02-28 05:46
MediWound Ltd. (NASDAQ:MDWD) Q4 2020 Earnings Conference Call February 25, 2021 8:30 AM ET Company Participants Jeremy Feffer - IR, LifeSci Advisors Sharon Malka - CEO Boaz Gur-Lavie - CFO Conference Call Participants Ryan Zimmerman - BTIG Kevin DeGeeter - Oppenheimer Joshua Jennings - Cowen Swayampakula Ramakanth - HC Wainwright Operator Ladies and gentlemen, thank you for standing by. Welcome to the MediWound Fourth Quarter 2020 Conference Call. I would now like to turn the call over to your speaker, Mr. ...
MediWound(MDWD) - 2020 Q4 - Annual Report
2021-02-25 12:53
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________________ to ____________________ OR ☐ SHELL COMPANY REPORT P ...